Fighting Tuberculosis: In Search of a BCG Replacement

Area of Science:

• Immunology and Vaccinology
• Infectious Diseases
• Microbiology

Background:

• Tuberculosis (TB) remains a major global health threat, causing significant mortality, particularly in high-burden areas.
• The existing Bacillus Calmette-Guérin (BCG) vaccine provides inconsistent and short-term protection against Mycobacterium tuberculosis (Mtb).
• Key immune correlates of protection against Mtb infection and disease progression remain incompletely understood despite extensive research.

Purpose of the Study:

• To review promising strategies for developing novel tuberculosis vaccines.
• To discuss the potential for new vaccines to replace or improve upon the current BCG vaccine.
• To explore innovative approaches addressing the challenges posed by Mtb's intracellular lifestyle and immune evasion mechanisms.

Main Methods:

• Review of current research and clinical evaluations of novel vaccine candidates.
• Analysis of strategies involving antigen supplementation in mycobacterial strains.
• Evaluation of genetic engineering approaches to modify Mtb-host cell interactions, such as phagosome escape.

Main Results:

• Several promising strategies are under investigation for next-generation tuberculosis vaccines.
• Vaccine candidates include modified BCG strains and Mtb strains with enhanced immunogenicity.
• Genetic modifications aim to improve bacterial survival, antigen presentation, and host immune response.

Conclusions:

• Significant scientific challenges exist in developing effective tuberculosis vaccines due to Mtb's complex biology.
• Innovative approaches like antigen enhancement and genetic engineering show potential for superior protection.
• Ongoing clinical evaluations of new vaccine strains offer hope for improved control of tuberculosis.